December 31, 2018 Share this content: There are 2 hypotheses on why high-intensity NIV is beneficial to individuals with hypercapnic stable COPD. There is evidence that people with comorbid stable chronic obstructive pulmonary disease (COPD) and chronic hypercapnic respiratory failure (CHRF) have improved symptoms and survival rates with high-intensity noninvasive ventilation (NIV), according to a… Read More »
The National Science Foundation has awarded a $ 224,793 grant to Vanguard Medical Technologies, an incubation firm, to find outcomes data for researchers. The firm is charged with developing technology that will enable clinical trials to use artificial intelligence to dive into an electronic health records system and cull out useful data. As regulatory bodies… Read More »
This study is something to keep in mind when we evaluate neonatal outcomes in mothers taking psychotropic medication. We typically consider maternal, but not paternal, characteristics as factors which may affect neonatal outcomes; however, this large study published in BMJ indicates that the age of the father may also affect neonatal outcomes. Researchers examined… Read More »
Lunesta (Eszopiclone) is a sleeping tablet prescribed by health professionals used for healing adults suffering from insomnia. Exactly like any other sleeping pills, there is a huge possibility of becoming reliant to the drug, consequently, making an individual dependent on it. Lunesta is permitted by FDA for extended use in treating insomnia compared to other… Read More »